As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis 

A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO 

Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right 

Covid Booster Costs Spur Calls to Shift From Free Jabs for All 

Congressional delays could undermine COVID-19 global fight 

How President Biden Can Expand Global COVID-19 Test-To-Treat 

African clinical trial denied access to key COVID drug Paxlovid 

Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first 

Rich countries are getting the new COVID vaccine first 

Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough 

A compromise is reached on an intellectual property waiver for Covid-19 vaccines, but does it go far enough? 

Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 

New “Compromise” on IP Waiver for Covid Vaccines Is Worse Than No Deal, Activists Say 

Covid Pill Prescriber Rules Limit Reach of ‘Test to Treat’ Plan 

Poor countries struggled to get covid vaccines. Now it’s happening with game-changing pills. 

Ukraine-Russia War Threatens to Stymie Covid Vaccination Efforts 

Four ways to beat the next pandemic 

Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries 

COVID inequity: In Africa, at-home tests are scarce, costly 

Such a deal! Covid-19 therapies appear cost-effective…for now 

SEE MORE